HomeCompareSGFY vs MRK

SGFY vs MRK: Dividend Comparison 2026

SGFY yields 6.56% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.0K in total portfolio value
10 years
SGFY
SGFY
● Live price
6.56%
Share price
$30.49
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.8K
Annual income
$0.68
Full SGFY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SGFY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSGFYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SGFY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SGFY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SGFY
Annual income on $10K today (after 15% tax)
$557.56/yr
After 10yr DRIP, annual income (after tax)
$0.58/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,327.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SGFY + MRK for your $10,000?

SGFY: 50%MRK: 50%
100% MRK50/50100% SGFY
Portfolio after 10yr
$38.8K
Annual income
$4,899.41/yr
Blended yield
12.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SGFY
Analyst Ratings
8
Buy
6
Hold
Consensus: Buy
Price Target
$27.33
-10.4% upside vs current
Range: $20.00 — $32.00
Altman Z
6.3
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SGFY buys
0
MRK buys
0
No recent congressional trades found for SGFY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSGFYMRK
Forward yield6.56%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$20.8K$56.8K
Annual income after 10y$0.68$9,798.13
Total dividends collected$668.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$27.33$128.54

Year-by-year: SGFY vs MRK ($10,000, DRIP)

YearSGFY PortfolioSGFY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,028$327.98$11,206$366.19$178.00MRK
2$11,969$169.01$12,650$502.35$681.00MRK
3$12,892$85.72$14,407$694.19$1.5KMRK
4$13,838$43.15$16,585$967.82$2.7KMRK
5$14,828$21.64$19,342$1,363.89$4.5KMRK
6$15,877$10.84$22,913$1,947.19$7.0KMRK
7$16,994$5.42$27,662$2,823.89$10.7KMRK
8$18,186$2.71$34,159$4,173.35$16.0KMRK
9$19,461$1.36$43,337$6,308.80$23.9KMRK
10$20,824$0.68$56,776$9,798.13$36.0KMRK

SGFY vs MRK: Complete Analysis 2026

SGFYStock

Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.

Full SGFY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SGFY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SGFY vs SCHDSGFY vs JEPISGFY vs OSGFY vs KOSGFY vs MAINSGFY vs JNJSGFY vs ABBVSGFY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.